CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ (2)	$ (16)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation and amortization	40	43
Amortization of right-of-use assets	8	3
Share-based compensation expense	13	11
Benefit for deferred income taxes	1	(3)
Amortization of debt issuance costs	1	1
Other	0	3
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable, net	(57)	(18)
Inventories, net	(44)	(33)
Other assets and liabilities	(43)	(49)
Accounts payable and accrued expenses	50	1
Net cash provided by (used for) operating activities	(33)	(57)
Cash flows from investing activities:
Investments in property, equipment, and software	(11)	(15)
Payments related to equity investments and business acquisitions, net of cash acquired	(18)	0
Net cash provided by (used for) investing activities	(29)	(15)
Cash flows from financing activities:
Proceeds from revolving line of credit	112	0
Repayments of Lines of Credit	(112)	0
Proceeds from share-based awards	2	1
Tax payments related to share-based awards	(4)	(3)
Payments related to the buy-out of non-controlling interests in subsidiaries of Covetrus	(3)	(1)
Net cash provided by (used for) financing activities	(5)	(3)
Effect of exchange rate changes on cash and cash equivalents	1	(4)
Net change in cash and cash equivalents	(66)	(79)
Cash and cash equivalents, beginning of period	183	290
Cash and cash equivalents, end of period	117	211
Supplemental disclosures of non-cash investing and financing activities:
Right-of-use assets obtained in exchange for new operating lease liabilities	7	3
Common stock issued in business acquisition	$ 10	$ 0